The Missouri Division of Cannabis Regulation (DCR), in a recent communication with state facility licensees, announced the extension of a series of temporary waivers and variances from the final cannabis regulation rules, originally set to take effect on July 30, 2023. These waivers, which delay the compliance requirements on certain aspects of cannabis testing and reporting, are designed to give licensees additional time to adapt to the new regulations.
Details of the Waiver and Variances Among the key waivers issued are:
- Delaying the requirement to test for additional cannabinoids such as THCV, CBDV, and Δ8-THC until December 28, 2023.
- Postponing the inclusion of vitamin E acetate in chemical residue screening for inhalables and concentrates.
- Temporarily waiving the residual solvent testing for raw plant material.
- Extending compliance on water activity and moisture content screening for certain marijuana products.
- Easing the requirements for foreign matter screening.
- Deferring the mandatory inclusion of terpene analysis in testing the licensee’s scope of accreditation.
Read more at mogreenway.com